PG Coin, AR Osornio-Vargas, VL Roggli and AR Brody
Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.

Previously, this laboratory developed a model of asbestos-induced pulmonary fibrogenesis in rats and mice after a brief (1 to 3-h) inhalation exposure. However, typical human environmental exposures would be repeated, although at lower concentrations than those used in our animal model. Here we have extended this model to encompass repeated exposures and consequent long-term effects. Groups of rats were exposed to chrysotile aerosol (10 mg/m3) for 3- to 5-h periods over 3 consecutive days. Lung fiber burden and pathologic features were studied for as long as 6 mo after exposure. We found that many of the longest (> or = 8 microm) fibers were retained in the lung for at least 6 mo, whereas shorter fibers were cleared more rapidly. The three exposures to chrysotile caused a large increase in DNA synthesis in the epithelium of terminal bronchioles and more proximal airways. When compared with a single exposure, the triple exposure caused an enhanced inflammatory response as well as a prolonged period of increased DNA synthesis in the proximal alveolar region. Hyperplastic, fibrotic lesions subsequently developed in the same region and persisted for at least 6 mo after exposure. These findings will be valuable in directing future studies of the mechanisms of pulmonary fibrosis in this model.

This article has been cited by other articles:

				A. Nelson, T. Mendoza, G. W. Hoyle, A. R. Brody, C. Fermin, and G. F. Morris Enhancement of Fibrogenesis by the p53 Tumor Suppressor Protein in Asbestos-Exposed Rodents Chest, July 1, 2001; 120(2007): 33S - 34S. [Full Text] [PDF]

				J. C. Bonner, A. B. Rice, C. R. Moomaw, and D. L. Morgan Airway fibrosis in rats induced by vanadium pentoxide Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L209 - L216. [Abstract] [Full Text] [PDF]

				A. B. Rice, C. R. Moomaw, D. L. Morgan, and J. C. Bonner Specific Inhibitors of Platelet-Derived Growth Factor or Epidermal Growth Factor Receptor Tyrosine Kinase Reduce Pulmonary Fibrosis in Rats Am. J. Pathol., July 1, 1999; 155(1): 213 - 221. [Abstract] [Full Text] [PDF]

				J. E. Boyle, P. M. Lindroos, A. B. Rice, L. Zhang, D. C. Zeldin, and J. C. Bonner Prostaglandin-E2 Counteracts Interleukin-1beta -Stimulated Upregulation of Platelet-Derived Growth Factor alpha -Receptor on Rat Pulmonary Myofibroblasts Am. J. Respir. Cell Mol. Biol., March 1, 1999; 20(3): 433 - 440. [Abstract] [Full Text]

				D. M. Brass, G. W. Hoyle, H. G. Poovey, J.-Y. Liu, and A. R. Brody Reduced Tumor Necrosis Factor-{alpha} and Transforming Growth Factor-ß1 Expression in the Lungs of Inbred Mice that Fail to Develop Fibroproliferative Lesions Consequent to Asbestos Exposure Am. J. Pathol., March 1, 1999; 154(3): 853 - 862. [Abstract] [Full Text] [PDF]

				J.-Y. Liu, G. F. Morris, W.-H. Lei, C. E. Hart, J. A. Lasky, and A. R. Brody Rapid Activation of PDGF-A and -B Expression at Sites of Lung Injury in Asbestos-exposed Rats Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 129 - 140. [Abstract] [Full Text]